Description

Mirtazapine Tablets IP 10 Mg – MITRACREST 10 Tablets
Composition  –Mirtazapine 10 mg

Description:
MITRACREST 10 contains Mirtazapine Tablet IP 10 mg, a noradrenergic and specific serotonergic antidepressant (NaSSA) indicated for the treatment of major depressive disorder (MDD). It works by blocking alpha-2 adrenergic autoreceptors and heteroreceptors, leading to enhancing the release of both norepinephrine and serotonin in the brain. Additionally, its antagonism at 5-HT2 and 5-HT3 receptors contributes to improved mood, reduced anxiety, and better sleep quality.
The 10 mg strength serves as an early titration dose, allowing gradual dose escalation toward therapeutic maintenance levels for sustained antidepressant effect.

Key Points
NaSSA Mechanism — Dual enhancement of norepinephrine and serotonin without reuptake inhibition
10 mg Strength — Suitable for early dose titration toward therapeutic maintenance levels
Improves Sleep Quality — Strong sedative and anxiolytic properties beneficial in depression with insomnia
Reduces Anxiety — Effective in managing anxiety symptoms co-existing with depression
Alternative to SSRIs/SNRIs — Suitable for patients with inadequate response or intolerance to first-line antidepressants

Targeted Specialties
Psychiatry
Neurology
General Physician & Internal Medicine